The distribution o f acyl moieties at sn-1 and sn-2 positions of cholinephosphoglycerides (CPG) and ethanolaminephosphoglycerides (EPG) has been determined for neurosarcoma, sarcoma 180 and leukemia L 1210. In all the three samples, the positional distribution o f acyl moieties in the two major classes o f phospholipids is found to be similar to that in cellular phospholipids o f most mammalian tissues. The saturated acyl moieties are located predominantly at sn-1 and polyunsaturated acyl moieties at sn-2, whereas the monounsaturated acyl moieties are randomly distributed between these two positions. Apparently, a disruption of specific positioning o f acyl moieties in phospholipids, which hitherto has been in neoplasia, does not exist in all neoplastic cells.
Introduction
Most cellular phospholipids exhibit specific posi tioning of saturated acyl moieties at sn-1 and poly unsaturated acyl moieties at sn-2 of the glycerol backbone, whereas monounsaturated acyl moieties are randomly located at these two positions [1, 2] . This specificity in the positional distribution of acyl moieties in phospholipids has been shown to be disrupted in several types of neoplastic cells [3] [4] [5] [6] [7] and such a metabolic deletion is considered to be one of the characteristic features of neoplasia [6] , A recent study has shown, however, that the positional specificity of acyl moieties in phospholipids of nor mal lymphocytes is essentially retained in rapidly growing leukemia L 1210 ascites cells [8] .
In order to examine, whether the abnormal posi tioning of acyl moieties in phospholipids is a gener al characteristic of neoplastic cells, we have studied the distribution of acyl moieties in the major phos pholipids of neurosarcoma, a slowly growing tumor, and of sarcoma 180 ascites cells. Moreover, we have reinvestigated the positioning of acyl moieties in the phospholipids of leukemia L 1210 cells. We have found that in the solid tumor as well as in the two types of ascites cells the specific positional distribu tion of saturated and unsaturated acyl moieties in the major classes of phospholipids is not disrupted.
Experimental
Neurosarcoma was grown in the back of male Sprague-Dawley rats as described elsewhere [9] . The tumors were removed from the adhering muscle tissue on the 22nd day after transplantation of the tumor. Ascites cells of sarcoma 180 and leukemia L 1210 were grown in the peritoneal cavity of female NMRI mice and transplanted weekly. The ascites cells were collected on the fifth day after transplantation. The cells were rinsed repeatedly with Hank's medium and isolated by centrifugation.
Tumor tissue as well as ascites cells from five animals, each, were pooled and lipids were extract ed with chloroform-methanol (1:2) according to an established procedure [10] . Total lipids were frac tionated on layers of silica gel H using chloroformmethanol-water (65:25:4) and the fractions of cho linephosphoglycerides (CPG) and ethanolamine phosphoglycerides (EPG) were, each, isolated [11] . These phospholipid fractions were hydrolyzed by phospholipase A2 from porcine pancreas [12] (Boehringer-Mannheim GmbH, Mannheim, Germany). The products of enzymatic hydrolysis, /. e. 1 -acyl phosphoglycerides and the fatty acids liberated from sn-2 of the glycerol backbone, were isolated by chro-matography on layers of silica gel H using chloroform-methanol-water (65:25:4) [11] . 1-Acylphosphoglycerides and the fatty acids were then con verted to the methyl esters [13] and analyzed by gas chromatography in a Perkin-Elmer F 22 instrument (Bodenseewerk Perkin-Elmer & Co. GmbH, Über lingen, Bundesrepublik Deutschland), equipped with flame ionization detectors. The methyl esters were separated on glass columns, 1.8 m by 3 mm, packed with EGSS-X on Gas Chrom P, 100-120 mesh (Applied Science Laboratories, Inc., State College, Pennsylvania, USA). Table I shows the positional distribution of acyl moieties in CPG and EPG of neurosarcoma, sar coma 180 and leukemia L 1210. The data show distinctly that in both major classes of phospho lipids in the three samples investigated the saturated and the polyunsaturated acyl moieties are located specifically at sn-1 and sn-2, respectively, whereas the monounsaturated acyl moieties are randomly distributed between positions s«-l and sn-2.
Results
Although the general pattern of distribution of acyl moieties in CPG and EPG of the solid neurosarco ma is similar to that in the sarcoma 180 and leukemia L 1210 ascites cells, several quantitative differences are observed in the distribution of indi vidual acyl moieties in the tumor, as compared to the ascites cells (Table I) . A striking feature of neurosarcoma is the occurrence of relatively large proportions of 15:0 and 17:0 acyl moieties, which occur almost exclusively at the sn-1 position of EPG. A low level of 16:0 acyl moieties at both sn-1 and sn-2 in EPG of neurosarcoma, as compared to the corresponding positions in CPG of neurosarco ma as well as both CPG and EPG of the two types of ascites cells, is noteworthy. As compared to neurosarcoma, the ascites cells are characterized by a low level of 18:0 at sn-1 position of EPG, elevated levels of 18:1 at both src-l and sn-2 of CPG as well as EPG, and a low level of 20:4 w 6 at sn-2 of both classes of phospholipids. The only exception is CPG of sarcoma 180, in which the level of 20:4 w 6 at sn-2 is as high as that at sn-2 in CPG of neurosarcoma. The levels of 18:2 w 6 at sn-2 of CPG and EPG of neurosarcoma are similar to those of the ascites cells, with the exception of leukemia L 1210, which contains a higher level of 18:2 w 6 at sn-2 of EPG than that at sn-2 in EPG of neurosarcoma.
Discussion
Our results (Table I) show that the "normal" positional distribution of acyl moieties in phospho lipids [1, 2] is not disrupted in the three types of neoplasia investigated. Apparently, a disruption of specific positioning of acyl moieties in phospho lipids, as reported for hepatomas [4] [5] [6] [7] , nephroma [6] and Ehrlich ascites cells [3] , is not a general feature of neoplasia.
The "abnormal" positioning of acyl moieties in phospholipids of certain types of hepatoma has been attributed to an alteration in the mechanism which controls the normal asymmetric distribution of fatty acids in naturally-occurring phospholipids [14] . It is generally agreed that the asymmetric positioning of saturated and unsaturated acyl moi eties in diacylglycerolipids occurs, partly, during the stepwise acylation of sw-glycerol 3-phosphate, which is catalyzed by acyl-CoA: SH-glycerol-3-phosphate acyltransferase and acyl-CoA: acyl-5«-glycerol-3-phosphate acyltransferase [15, 16] . Since all spe cies of diacylglycerophospholipids should arise through the key intermediate, acyl-s«-glycerol-3-phosphate, the specific positioning of acyl moieties in such lipids is likely to be regulated by acyl-CoA: .s«-glycerol-3-phosphate acyltransferase. This enzyme has been detected in both microsomes and mito chondria of several mammalian organs [17] , The mitochondrial acyl-CoA: sn-glycerol-3-phosphate acyltransferase, in contrast to its microsomal coun terpart, specifically catalyzes the acylation of sn-1 with saturated acyl moieties, and this particular enzyme is believed to be primarily responsible for the specific positional distribution of acyl moieties in phospholipids [17] , Cultured cells and Ehrlich ascites tumor cells have been shown to be deficient in mitochondrial acyl-CoA: 5/7-glycerol-3-phosphate acyltransferase, which seems to have a bearing on the abnormal positioning of acyl moieties in the phospholipids of these cells [17, 18] , Our data on the distribution of acyl moieties in the major phospho lipids of solid neurosarcoma, sarcoma 180 and leukemia L 1210 ascites cells (Table I) as well as pre vious data on leukemia L 1210 cells [8] suggest that a deficiency of the mitochondrial acyl-CoA: M-glycerol-3-phosphate acyltransferase might not be a cha racteristic feature of all tumor cells.
